MaxCyte, Inc. Files 2024 10-K

Ticker: MXCT · Form: 10-K · Filed: Mar 11, 2025 · CIK: 1287098

Maxcyte, INC. 10-K Filing Summary
FieldDetail
CompanyMaxcyte, INC. (MXCT)
Form Type10-K
Filed DateMar 11, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-K, annual-report, financials

TL;DR

MaxCyte's 2024 10-K is in, check out their financials for year-end 2024.

AI Summary

MaxCyte, Inc. filed its 2024 10-K on March 11, 2025, reporting its financial performance for the fiscal year ending December 31, 2024. The filing details the company's business operations, financial statements, and risk factors. Key financial data such as retained earnings and additional paid-in capital for the years ending December 31, 2024, 2023, and 2022 are presented.

Why It Matters

This 10-K filing provides investors and stakeholders with a comprehensive overview of MaxCyte's financial health and strategic positioning as of December 31, 2024.

Risk Assessment

Risk Level: medium — The filing is a standard annual report, but the inherent risks of the biotechnology sector and specific company operations are not detailed here.

Key Numbers

Key Players & Entities

FAQ

What is MaxCyte, Inc.'s primary business activity?

MaxCyte, Inc. is involved in Services-Commercial Physical & Biological Research, with a specific focus on industrial applications and services.

When was the 10-K filing submitted to the SEC?

The 10-K filing was submitted on March 11, 2025.

What is the fiscal year end for MaxCyte, Inc.?

MaxCyte, Inc.'s fiscal year ends on December 31.

Where is MaxCyte, Inc. headquartered?

MaxCyte, Inc.'s business address is located at 9713 Key West Avenue, Suite 400, Rockville, MD 20850.

What is the SEC file number for MaxCyte, Inc.'s 10-K filing?

The SEC file number for this 10-K filing is 001-40674.

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on March 11, 2025 regarding MAXCYTE, INC. (MXCT).

View full filing on EDGAR

View Full Filing

View this 10-K filing on SEC EDGAR

View on Read The Filing